NKCFO LLC’s Neuronetics STIM Stock Holding History

NKCFO LLC’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-75,000	Closed	-$262K	–	135
2025 Q2	$262K	Sell	75,000 -50,000	-40%	-$197K	0.11%	62
2025 Q1	$460K	Buy	+125,000	New	+$456K	0.21%	43

Other funds holding STIM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NKCFO LLC's STIM Position: Q3 2025 in Review

NKCFO LLC sold out of Neuronetics (STIM) in Q3 2025, closing a stake of 75,000 shares — an estimated $262K sold.

NKCFO LLC first reported a position in STIM in Q1 2025 and held it in 2 quarters. The position peaked at $460K in Q1 2025. 99 funds tracked by Wall St. Rank hold STIM as of Q3 2025.

NKCFO LLC reported no remaining Neuronetics position as of Q3 2025 after selling out during the quarter.
NKCFO LLC sold 75,000 Neuronetics shares in Q3 2025, an estimated $262K.
NKCFO LLC first reported a position in Neuronetics in Q1 2025 and held it in 2 quarters.
NKCFO LLC's Neuronetics position peaked at $460K in Q1 2025.
99 funds tracked by Wall St. Rank held Neuronetics as of Q3 2025.

Based on NKCFO LLC's 13F filing for Q3 2025, filed 10 Nov 2025.